Mechanisms regulating vimentin-dependent invasion of the brain by Listeria monocytogenes
单核细胞增生李斯特菌依赖波形蛋白入侵大脑的调节机制
基本信息
- 批准号:10183151
- 负责人:
- 金额:$ 38.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-26 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAntibodiesAstrocytesBacteriaBacterial InfectionsBindingBinding ProteinsBiochemicalBiologicalBiological AssayBloodBlood - brain barrier anatomyBrainCause of DeathCell ExtractsCell surfaceCellsCellular MembraneCultured CellsDiseaseElderlyEncephalitisEndothelial CellsFamily memberFluorescence MicroscopyGastroenteritisGentamicinsGoalsHumanImmunocompromised HostImmunoprecipitationIn VitroIndividualInfectionInfection preventionIntermediate Filament ProteinsIntestinesInvadedKnock-outKnockout MiceLeadLengthLifeLigandsListeria monocytogenesMass Spectrum AnalysisMediatingMembraneMembrane ProteinsMeningitisMultigene FamilyMusNeuraxisNeuronsPathway interactionsPhagocytesPlayPregnant WomenProtein FamilyProteinsRoleSurfaceVimentinblood-brain barrier crossingbrain cellbrain endothelial cellcell typeexperimental studyfoodbornegel electrophoresisin vivoinsightnovelnovel strategiespathogenpathogenic bacteriapathogenic microbepreventprotein protein interactionreceptorrepaired
项目摘要
Project Summary
Listeria monocytogenes (Lm) is an intracellular bacterial pathogen capable of invading numerous host
cell types. Lm infections can lead to severe disease in humans and most often affects immunocompromised
individuals, pregnant women, and the elderly. Of particular concern is the ability of Lm to invade the central
nervous system (CNS), leading to life-threatening meningitis and encephalitis. The identity of factors necessary
to facilitate Lm brain infection has remained unclear. We have recently shown that a Lm surface protein, InlF,
is required for successful colonization of the brain in mice. Moreover, we have determined that InlF binds
vimentin, a cytosolic intermediate filament protein also present on the surface of brain endothelial cells. We
hypothesize that InlF-vimentin interaction is required for Lm passage across the blood-brain barrier (BBB) to
establish an infection in the brain. The focus of this proposal is to elucidate how the InlF-vimentin interaction
mediates invasion of host cells in vitro and Lm infection of the brain in vivo. In Aim I, in vitro infection assays
will be used to determine how InlF interacts with vimentin to mediate invasion of host cells. Confocal
fluorescence microscopy and gentamicin protection assays will be used to directly examine the ability of InlF-
expressing Lm to interact with brain microvascular endothelial cells. Biochemical approaches will be used to
further characterize InlF-vimentin protein binding and identify the regions of vimentin involved in the InlF-
vimentin protein-protein interaction. The mechanisms that regulate cell surface exposure of vimentin are
unknown. We hypothesize that cellular membrane repair pathways facilitate redistribution of cytosolic vimentin
to the surface of host cells. Cell biological studies will be performed to determine the role of membrane repair
pathways for the localization of vimentin to the host cell surface. Additionally, potential vimentin co-receptor
candidates previously identified by mass spectrometry will be examined to determine their role in InlF-mediated
invasion of brain endothelial cells. In Aim II, the contribution of the InlF-vimentin interaction to Lm infection in
vivo will be determined by infection studies in normal and vimentin knockout mice. In vitro infection assays and
fluorescence microscopy will be performed with primary brain cells cultured from normal and knockout mice to
determine if InlF mediates invasion of distinct primary brain cell types (astrocytes and neurons) and determine
the importance of vimentin and potential co-receptors for infection. Gentamicin protection assays with primary
mouse endothelial cells will also be performed to determine if InlF is required for invasion of primary cells that
constitute the BBB. Finally, infection of mice with cell-to-cell spread-defective ΔactA or ΔactA/ΔinlF-derived Lm
strains will determine the in vivo contribution of InlF for colonization of the brain by direct invasion vs. cell-to-
cell spread. The proposed studies will provide insights into the protein-protein interactions and cellular
mechanisms facilitating Lm invasion of the brain and may identify novel targets for preventing infections of the
brain by Lm and other microbial pathogens.
项目摘要
单核细胞增多性李斯特菌是一种能侵袭多种宿主的胞内致病菌
单元类型。肺炎衣原体感染可导致人类严重疾病,最常见的是影响免疫功能低下
个人、孕妇和老年人。特别令人担忧的是LM入侵中央的能力
神经系统(CNS),导致危及生命的脑膜炎和脑炎。必要因素的同一性
促进LM脑部感染的机制尚不清楚。我们最近发现了一种名为Lm表面蛋白InlF,
是成功在小鼠体内定植大脑所必需的。此外,我们已经确定InlF与
波形蛋白是一种胞浆中间丝蛋白,也存在于脑内皮细胞表面。我们
假设LM通过血脑屏障(BBB)需要InlF-Vimentin相互作用
在大脑中建立感染。这一提议的重点是阐明InlF-Vimentin如何相互作用
在体外介导宿主细胞的侵袭,在体内介导脑部的LM感染。在AIM I中,体外感染分析
将用于确定InlF如何与Vimentin相互作用以介导宿主细胞的侵袭。共焦
荧光显微镜和庆大霉素保护试验将用于直接检测InlF-
表达LM与脑微血管内皮细胞相互作用。将使用生化方法来
进一步鉴定InlF-Vimentin蛋白结合,并鉴定参与InlF-Vimentin的区域
波形蛋白-蛋白质相互作用。调节细胞表面波形蛋白暴露的机制是
未知。我们假设细胞膜修复途径促进胞浆波形蛋白的重新分布
到宿主细胞的表面。将进行细胞生物学研究,以确定膜修复的作用
波形蛋白定位于宿主细胞表面的途径。此外,潜在的波形蛋白共受体
之前通过质谱学确定的候选人将接受检查,以确定他们在InlF中介中的角色
脑内皮细胞的侵袭。在AIM II中,InlF-Vimentin相互作用在肺炎衣原体感染中的作用
活体将通过对正常和波形蛋白基因敲除小鼠的感染研究来确定。体外感染检测和
荧光显微镜将对培养自正常和基因敲除小鼠的原代脑细胞进行
确定InlF是否介导不同的原代脑细胞类型(星形胶质细胞和神经元)的侵袭,并确定
波形蛋白和潜在的辅助受体对感染的重要性。庆大霉素保护性试剂盒
还将对小鼠内皮细胞进行检查,以确定InlF是否是侵袭原代细胞所必需的
构成了血脑屏障。最后,小鼠感染细胞间传播缺陷的ΔActA或ΔActA/Δ在F来源的LM中
菌株将确定InlF在体内通过直接侵袭与细胞侵袭对大脑定植的贡献。
细胞扩散。拟议的研究将提供对蛋白质-蛋白质相互作用和细胞
促进肺炎衣原体侵袭大脑的机制,并可能确定预防肺炎衣原体感染的新靶点
脑部受金黄色葡萄球菌等微生物病原体感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Hunter Brumell其他文献
John Hunter Brumell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Hunter Brumell', 18)}}的其他基金
Mechanisms regulating vimentin-dependent invasion of the brain by Listeria monocytogenes
单核细胞增生李斯特菌依赖波形蛋白入侵大脑的调节机制
- 批准号:
10415880 - 财政年份:2019
- 资助金额:
$ 38.53万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 38.53万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 38.53万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 38.53万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 38.53万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 38.53万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 38.53万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 38.53万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 38.53万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 38.53万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 38.53万 - 项目类别: